The Emerging Facets of Non-Cancerous Warburg Effect

Alyaa M. Abdel-Haleem, Nathan E. Lewis, Neema Jamshidi, Katsuhiko Mineta, Xin Gao, Takashi Gojobori

Research output: Contribution to journalArticlepeer-review

56 Scopus citations


The Warburg effect (WE), or aerobic glycolysis, is commonly recognized as a hallmark of cancer and has been extensively studied for potential anti-cancer therapeutics development. Beyond cancer, the WE plays an important role in many other cell types involved in immunity, angiogenesis, pluripotency, and infection by pathogens (e.g., malaria). Here, we review the WE in non-cancerous context as a
Original languageEnglish (US)
JournalFrontiers in Endocrinology
Issue numberOCT
StatePublished - Oct 23 2017

Bibliographical note

KAUST Repository Item: Exported on 2020-10-01
Acknowledged KAUST grant number(s): URF/1/1976-03
Acknowledgements: AMA, XG, KM, and TG acknowledge funding from King Abdullah University of Science and Technology (KAUST) and the Office of Sponsored Research (OSR) under Award No. URF/1/1976-03. NL acknowledges generous support from the Novo Nordisk Foundation grant NNF10CC1016517 and NIH (R35-GM119850 and R01 AI090141).


Dive into the research topics of 'The Emerging Facets of Non-Cancerous Warburg Effect'. Together they form a unique fingerprint.

Cite this